Attached files

file filename
8-K - 8-K - EKSO BIONICS HOLDINGS, INC.v427793_8k.htm
EX-5.1 - EXHIBIT 5.1 - EKSO BIONICS HOLDINGS, INC.v427793_ex5-1.htm
EX-4.1 - EXHIBIT 4.1 - EKSO BIONICS HOLDINGS, INC.v427793_ex4-1.htm
EX-3.1 - EXHIBIT 3.1 - EKSO BIONICS HOLDINGS, INC.v427793_ex3-1.htm
EX-99.2 - EXHIBIT 99.2 - EKSO BIONICS HOLDINGS, INC.v427793_ex99-2.htm
EX-10.2 - EXHIBIT 10.2 - EKSO BIONICS HOLDINGS, INC.v427793_ex10-2.htm
EX-10.1 - EXHIBIT 10.1 - EKSO BIONICS HOLDINGS, INC.v427793_ex10-1.htm

 

Exhibit 99.1

 

The registrant is filing this Exhibit 99.1 for the purpose of incorporating the information set forth herein by reference into the registration statement on Form S-3 (No. 333-205168) that was filed with the Securities and Exchange Commission on June 23, 2015 and became effective on July 9, 2015.

 

The following table sets forth the estimated costs and expenses (other than the actual FINRA filing fee), other than underwriting discounts and commissions, payable by the registrant in connection with the sale of the securities being registered:

 

FINRA Filing Fee  $11,750 
Printing and Engraving Expenses   3,500 
Legal Fees and Expenses   210,000 
Accounting Fees and Expenses   55,000 
Transfer Agent and Registrar Fees   0 
Miscellaneous   96,000 
Total  $376,250